Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets ; volume:40 ; number:1 ; day:18 ; month:5 ; year:2021 ; pages:1-23 ; date:12.2021
Journal of experimental & clinical cancer research ; 40, Heft 1 (18.5.2021), 1-23, 12.2021
- Creator
-
Luo, Xiang-Yuan
Wu, Kong-Ming
He, Xing-Xing
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-021-01968-w
- URN
-
urn:nbn:de:101:1-2021091719560335340364
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Luo, Xiang-Yuan
- Wu, Kong-Ming
- He, Xing-Xing
- SpringerLink (Online service)
Other Objects (12)
FXYD6: a novel therapeutic target toward hepatocellular carcinoma
Noncoding RNA as Therapeutic Targets for Hepatocellular Carcinoma
CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinoma
Novel targets and therapeutic strategies for the treatment of hepatocellular carcinoma (HCC)
RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma
Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Inflammation as a therapeutic target for osteoarthritis: A literature review of clinical trials
Advances in management of hepatocellular cancer
Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma
DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
Recent Advances in Anti‐Atherosclerosis and Potential Therapeutic Targets for Nanomaterial‐Derived Drug Formulations
FXYD6: a novel therapeutic target toward hepatocellular carcinoma
Noncoding RNA as Therapeutic Targets for Hepatocellular Carcinoma
CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinoma
Novel targets and therapeutic strategies for the treatment of hepatocellular carcinoma (HCC)
RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma
Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Inflammation as a therapeutic target for osteoarthritis: A literature review of clinical trials
Advances in management of hepatocellular cancer
Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma
DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
Recent Advances in Anti‐Atherosclerosis and Potential Therapeutic Targets for Nanomaterial‐Derived Drug Formulations
FXYD6: a novel therapeutic target toward hepatocellular carcinoma
Noncoding RNA as Therapeutic Targets for Hepatocellular Carcinoma
CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinoma
Novel targets and therapeutic strategies for the treatment of hepatocellular carcinoma (HCC)
RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma
Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Inflammation as a therapeutic target for osteoarthritis: A literature review of clinical trials
Advances in management of hepatocellular cancer
Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma
DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer